A Phase 3, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of anti-spike SARS-CoV-2 monoclonal antibodies in preventing SARS-CoV-2 infection in household contacts of individuals infected with SARS-CoV-2. (2069)

Objective

Clinical Trial Details >>

Principal Investigator(s)
Jawad Nazir, MD

Clinical Trial Categories

  • Adult
Sponsor(s)
Regeneron Pharmaceuticals
Contact
Avera Research Institute at 605-504-3154
or ARI@Avera.org

Location

  • Avera Medical Group Infectious Disease Specialists
    6709 S Minnesota Avenue
    Suite 102
    Sioux Falls, SD 57108
    Main: 605-322-7250
  • Avera Research Institute — Sioux Falls
    6001 S Sharon Ave
    Sioux Falls, SD 57108
    Main: 605-504-3154